Chong Kun Dang Pharmaceutical Corp. (KRX:185750)
South Korea
· Delayed Price · Currency is KRW 87,000
-400 (-0.46%)
At close: Dec 5, 2025
Chong Kun Dang Pharmaceutical Company Description
Chong Kun Dang Pharmaceutical Corp. engages in the manufacturing, marketing, and sales of medicines in South Korea and internationally.
The company provides prescription drugs for anti-hypertension, anti-hyperlipidemia, anti-diabetics, and immunosuppressants; over-the-counter medicine comprising headache remedies, dewormers, digestive aids, and vitamins; probiotics and Omega-3 supplements; and health drinks, hair dyes, and insecticides.
It also exports its products. The company was founded in 1941 and is headquartered in Seoul, South Korea.
Chong Kun Dang Pharmaceutical Corp.
| Country | South Korea |
| Founded | 1941 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 2,253 |
| CEO | Young-Joo Kim |
Contact Details
Address: Chong Kun Dang Building Seoul South Korea | |
| Phone | 82 2 2194 0300 |
| Website | ckdpharm.com |
Stock Details
| Ticker Symbol | 185750 |
| Exchange | Korea Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| ISIN Number | KR7185750007 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Young-Joo Kim | President, Chief Executive Officer and Chairman |